Douglas W. Mahoney

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid

  Journal of Surgical Oncology · 2026-06-01

• Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding

  Gynecologic Oncology · 2026-04-10 · 1 citations

• Validation of Methylated DNA Markers for Esophageal Squamous Cancer: An International Study

  Cancer Prevention Research · 2026-01-12

• Table 2 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  2026-01-06

• Supplemental Table 1 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  2026-01-06

• Data from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  2026-01-06

• Figure 3 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  2026-01-06

• Table 1 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  2026-01-06

• Figure 2 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  2026-01-06

• Figure 4 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  2026-01-06

• Optimization of Methylated DNA Markers to Rule Out Endometrial Cancer in Patients with Abnormal Uterine BleedingPreprint

  SSRN Electronic Journal · 2026-01-01

• Molecular Early Detection for Pancreatic Cancer in High-Risk Individuals: Are We Sure Yet?

  Gastroenterology · 2025-12-18

• Plasma assay of methylated DNA markers detects recurrent metastatic breast cancer

  npj Breast Cancer · 2025-11-29

• Supplemental Figure 1 from Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers

  2025-11-24

• Supplemental Figure 2 from Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers

  2025-11-24

• Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

  Cancer Prevention Research · 2025-10-07 · 3 citations

• Development of an endometrial cancer test for evaluating abnormal uterine bleeding

  Gynecologic Oncology · 2025-09-01

• Feasibility of vaginal tampon versus swab in the collection of vaginal fluid for endometrial cancer testing.

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Evaluation of plasma methylated DNA markers for detection HPV-positive oropharyngeal squamous cell carcinoma: A case control study.

  Journal of Clinical Oncology · 2025-05-28

• Mo1171: LOWER THAN EXPECTED INCIDENCE OF AERODIGESTIVE CANCER AFTER NEGATIVE HIGH-QUALITY FOLLOW-UP COLONOSCOPY FOR POSITIVE MULTITARGET STOOL DNA TESTS

  Gastroenterology · 2025-05-01